Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to 0.87.

  • Adma Biologics' Asset Utilization Ratio fell 1314.59% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 1314.59%. This contributed to the annual value of 1.04 for FY2024, which is 3683.99% up from last year.
  • Per Adma Biologics' latest filing, its Asset Utilization Ratio stood at 0.87 for Q3 2025, which was down 1314.59% from 0.89 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Asset Utilization Ratio registered a high of 1.03 during Q2 2024, and its lowest value of 0.22 during Q1 2021.
  • For the 5-year period, Adma Biologics' Asset Utilization Ratio averaged around 0.69, with its median value being 0.67 (2022).
  • In the last 5 years, Adma Biologics' Asset Utilization Ratio soared by 13957.89% in 2022 and then plummeted by 1350.22% in 2025.
  • Over the past 5 years, Adma Biologics' Asset Utilization Ratio (Quarter) stood at 0.43 in 2021, then soared by 41.33% to 0.6 in 2022, then soared by 47.56% to 0.89 in 2023, then grew by 9.29% to 0.97 in 2024, then decreased by 10.62% to 0.87 in 2025.
  • Its Asset Utilization Ratio was 0.87 in Q3 2025, compared to 0.89 in Q2 2025 and 0.92 in Q1 2025.